COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Bispecific Antibodies
  • 1.4.3 Antibody Drug Conjugates
  • 1.4.4 Chimeric Antigen Receptor T-Cells
• 1.5 Market by Application
  • 1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2026
  • 1.5.2 Liver Cancer
  • 1.5.3 Respiratory Cancer
  • 1.5.4 Brain Cancer
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry
    • 1.6.1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and B-Cell Maturation Antigen(BCMA) Targeted Therapies Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Perspective (2015-2026)
• 2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Trends by Regions
  • 2.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Share by Regions (2015-2020)
  • 2.2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth Strategy
  • 2.3.6 Primary Interviews with Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Market Size
  • 3.1.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Revenue (2015-2020)
  • 3.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio
  • 3.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2019
• 3.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players Head office and Area Served
• 3.4 Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service
• 3.5 Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Type (2015-2020)
• 4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2021-2026)

5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Application (2015-2026)

• 5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
• 5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2019-2020)
• 6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Europe (2019-2020)
• 7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 7.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

8 China

• 8.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 8.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in China (2019-2020)
• 8.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 8.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Japan (2019-2020)
• 9.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 9.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 10.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

11 India

• 11.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 11.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in India (2019-2020)
• 11.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 11.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
• 12.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Central & South America (2019-2020)
• 12.3 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
• 12.4 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Transposagen Biopharmaceuticals
  • 13.1.1 Transposagen Biopharmaceuticals Company Details
  • 13.1.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue
  • 13.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.1.4 Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020))
  • 13.1.5 Transposagen Biopharmaceuticals Recent Development
• 13.2 Sutro Biopharma
  • 13.2.1 Sutro Biopharma Company Details
  • 13.2.2 Sutro Biopharma Business Overview and Its Total Revenue
  • 13.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.2.4 Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.2.5 Sutro Biopharma Recent Development
• 13.3 Malin Corporation
  • 13.3.1 Malin Corporation Company Details
  • 13.3.2 Malin Corporation Business Overview and Its Total Revenue
  • 13.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.3.4 Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.3.5 Malin Corporation Recent Development
• 13.4 Eureka Therapeutics
  • 13.4.1 Eureka Therapeutics Company Details
  • 13.4.2 Eureka Therapeutics Business Overview and Its Total Revenue
  • 13.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.4.4 Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.4.5 Eureka Therapeutics Recent Development
• 13.5 firstVentury Equity
  • 13.5.1 firstVentury Equity Company Details
  • 13.5.2 firstVentury Equity Business Overview and Its Total Revenue
  • 13.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.5.4 firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.5.5 firstVentury Equity Recent Development
• 13.6 Five Prime Therapeutics
  • 13.6.1 Five Prime Therapeutics Company Details
  • 13.6.2 Five Prime Therapeutics Business Overview and Its Total Revenue
  • 13.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.6.4 Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.6.5 Five Prime Therapeutics Recent Development
• 13.7 Credit Suisse Securities
  • 13.7.1 Credit Suisse Securities Company Details
  • 13.7.2 Credit Suisse Securities Business Overview and Its Total Revenue
  • 13.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.7.4 Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.7.5 Credit Suisse Securities Recent Development
• 13.8 Dana-Farber Cancer Institute
  • 13.8.1 Dana-Farber Cancer Institute Company Details
  • 13.8.2 Dana-Farber Cancer Institute Business Overview and Its Total Revenue
  • 13.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.8.4 Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.8.5 Dana-Farber Cancer Institute Recent Development
• 13.9 Deerfield Partners
  • 13.9.1 Deerfield Partners Company Details
  • 13.9.2 Deerfield Partners Business Overview and Its Total Revenue
  • 13.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.9.4 Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.9.5 Deerfield Partners Recent Development
• 13.10 Onyx Pharmaceuticals
  • 13.10.1 Onyx Pharmaceuticals Company Details
  • 13.10.2 Onyx Pharmaceuticals Business Overview and Its Total Revenue
  • 13.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 13.10.4 Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 13.10.5 Onyx Pharmaceuticals Recent Development
• 13.11 Juno Therapeutics
  • 10.11.1 Juno Therapeutics Company Details
  • 10.11.2 Juno Therapeutics Business Overview and Its Total Revenue
  • 10.11.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  • 10.11.4 Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  • 10.11.5 Juno Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer